Budgeting for Opioid Addiction Treatment Act
- Last Action
- 7/27/2023
Actions
- 2023-07-27Read twice and referred to the Committee on Finance.
- 2023-07-27Introduced in Senate
CRS Summary
As of 2023-07-27 (00)
Budgeting for Opioid Addiction Treatment Act
This bill imposes an excise tax on the sale of any active opioid. The tax is equal to one cent per milligram so sold and it is imposed on the manufacturer, producer, or importer of the opioid. The term active opioid means any controlled substance that is opium, an opiate, or any derivative thereof.
The bill provides block grants for substance abuse treatment programs.
The Department of Health and Human Services must report on the impact of this bill on (1) the retail cost of active opioids; (2) patient access to such opioids, particularly cancer and hospice patients; and (3) the use of tax revenues to improve substance abuse treatment efforts. The report must also make suggestions for improving access to opioids for cancer and hospice patients and substance abuse treatment efforts.
Cosponsors (9)
- Mitt Romney (R-UT)
- Elizabeth Warren (D-MA)
- Richard Blumenthal (D-CT)
- Angus King (I-ME)
- Tina Smith (D-MN)
- Jeanne Shaheen (D-NH)
- Amy Klobuchar (D-MN)
- Tammy Baldwin (D-WI)
- Sheldon Whitehouse (D-RI)
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.